To establish a celiac disease screening pilot program
Summary
This bill directs the Massachusetts Department of Public Health to create a three-year pilot program to test the feasibility of adding celiac disease screening when health care providers conduct cholesterol and lipid screenings for 12-year-olds. The bill defines celiac disease, identifies the types of providers eligible to participate, and frames the program as an effort to improve early detection, reduce long-term health consequences, and help families manage a diagnosis.
The program would be voluntary for health care providers and offered at no additional cost to them. Participating providers would collect screening data as determined by the department, and the department would provide educational materials and family support resources. The bill also requires the department to work with providers, insurers, and patient advocacy groups, and to use the pilot to assess feasibility, accuracy, and outcomes of screening in this age group.
Impact
The bill would add a new public health pilot program under the Department of Public Health rather than directly amending existing disease-screening mandates. It would authorize the department to coordinate celiac screening in connection with existing pediatric cholesterol and lipid screenings, collect data from participating providers, and issue annual reports to legislative committees and clerks. The bill could affect pediatric health care providers, hospitals, clinics, insurers, and families of children diagnosed with celiac disease, while any implementation funding would be subject to appropriation.
Sentiment
The bill appears generally favorable in concept, with a public health and preventive care focus and no recorded votes or committee testimony indicating opposition in the provided materials. Its emergency preamble suggests the sponsor views the measure as time-sensitive and important to implement quickly. The overall tone is proactive and supportive of early diagnosis, family education, and evidence gathering before any broader statewide expansion.
Contention
The main points of potential contention are likely to be cost, administrative burden, and the uncertainty of whether celiac screening should be added to routine pediatric lipid testing. The bill says participation is at no additional cost to providers, but it also makes implementation subject to appropriation and requires data collection and annual reporting, which could raise concerns about funding and workload. Another possible issue is whether the pilot’s evidence will be sufficient to justify statewide expansion, especially given questions about screening accuracy, feasibility, and cost savings.